Gerald Chodak, MD, 72, who created the intellectual framework for the active surveillance (AS) approach followed by hundreds of thousands of men with low-risk prostate cancer and an opponent of routine prostate specific antigen (PSA) testing, died Sept. 28 at his home in Michigan City, Indiana. The cause was reported to be an aortic aneurysm.
He was a lightning rod for controversy who often took on the medical establishment, resulting in professional isolation.
He was considered the "father of active surveillance," said Chodak was a role model and was the first in the field to propose conservative management of prostate cancer. He said Chodak's concepts led in 1997 to the developing of the concept of AS with close monitoring of patients with low-risk prostate cancer.
"His argument was that we were over-treating patients. And he was, I would say, the first to really make that argument in a compelling way. And he really took on the establishment," We will truly miss him.